The Prevalence of COVID-19 in Europe by the End of November 2022: A Cross-Sectional Study

被引:9
|
作者
Alrasheedi, Ahmad A. [1 ]
机构
[1] Qassim Univ, Dept Family & Community Med, Buraydah, Saudi Arabia
关键词
median age; vaccine; testing; european union; europe; covid-19; coronavirus; case-fatality; SARS-COV-2;
D O I
10.7759/cureus.33546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The world has been affected differently by the coronavirus disease 2019 (COVID-19), and Europe reaped the largest number of cases and deaths. Moreover, COVID-19 statistics are dynamic. Objectives The current study aimed to use COVID-19 data to examine the COVID-19 prevalence in Europe by the end of November 2022 and compare the findings globally. Methods The primary data on COVID-19 for each European country were obtained from the "Worldometer" website. The data include the cumulative incidence of COVID-19 per country, the cumulative number of deaths, the total number of tests performed, the number of cases per million population, the number of deaths per million, the number of tests per million, and the total population. The case-fatality rate was calculated (number of deaths/number of cases). In addition, the median age and the vaccination coverage rate (people who received two doses) for each European country were extracted from the "United Nations" website and the "Our World in Data" website, respectively. To compare European countries to the globe, COVID-19 data for each continent were obtained. The analysis of variance (ANOVA) test was used to compare variances across the means of the four parts of Europe based on the geographic division. An independent sample t-test was also used to compare the means between the European Union (EU) states and non-EU states. The Spearman correlation coefficient was used to determine the relationship between different variables across Europe. Results As of December 1, 2022, about 648 million COVID-19 cases and 6.6 million deaths have been recorded worldwide. Europe accounted for nearly 36.8% and 29.5% of all cases and deaths, respectively. Based on the number of deaths per million, Europe was the most affected continent after South America. Nearly 6.8 billion tests have been conducted worldwide, 41% done in Europe; 43 European countries have performed tests more than their population. However, COVID-19 statistics were inconsistent across the four parts of Europe. A significant difference was noticed between Eastern Europe and others, especially Northern Europe and Western Europe. By affiliation with the EU, there was no significant difference. For global comparison, the mean deaths per million, the mean cases per million, and the mean tests per population for European countries were higher than those of the world's countries, although they recorded a lower mean case-fatality rate (CFR). Thirteen European countries were among the 15 most affected countries worldwide based on the number of deaths per million, most located in Eastern and Southern Europe. The number of cases and the number of deaths were significantly proportional to the number of tests performed. Conclusions By the end of November 2022, Europe had the most cases of COVID-19, the most deaths, and the most tests performed, even though it accounts for 9.4% of the world's population. However, COVID-19 data were inconsistent across the four parts of Europe, especially between Eastern Europe and others. Given the natural immunity acquired during the three years and the excellent vaccine coverage in Europe, it is essential to reconsider the definition of a suspected case and establish more specific criteria for testing.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Prevalence and factors associated with belief in COVID-19 vaccine efficacy in Indonesia: A cross-sectional study
    Diyan Ermawan Effendi
    Agung Dwi Laksono
    Setia Pranata
    Zainul Khaqiqi Nantabah
    Asian Pacific Journal of Tropical Medicine, 2022, (07) : 308 - 313
  • [32] Hypoalbuminemia in burn patients with COVID-19: a cross-sectional study
    Noviana, Heri
    Saputro, Iswinarno Doso
    Handriani, Ira
    BALI MEDICAL JOURNAL, 2023, 12 (03) : 3201 - 3205
  • [33] COVID-19 Vaccines and the Menstrual Cycle: A Cross-Sectional Study
    Al-Husban, Naser
    Al-Najjar, Sondos
    Alkubaisi, Fatima Abdulsattar
    Alzibdeh, Abdulla M.
    Yasin, Kenan A. S.
    Alhusban, Alhareth Eid
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2024, 20 (01) : 24 - 30
  • [34] COVID-19 vaccine hesitancy in Egypt: a cross-sectional study
    Shawki, May Ahmed
    Kamel, Ahmed
    Gamal, Shaza
    Abbassi, Maggie Magdy
    Farid, Samar Farghali
    Sabry, Nirmeen Ahmed
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (09): : 1188 - +
  • [35] Focused Ultrasonography in COVID-19: A Prospective Cross-sectional Study
    Mathew, Manju
    Kalliath, Antony
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (06) : OC21 - OC25
  • [36] The acceptance of COVID-19 vaccines in Rwanda: a cross-sectional study
    Mbonigaba, Edward
    Yu, Fengyun
    Renosa, Mark Donald C.
    Mwikarago, Ivan Emil
    Cho, Frederick Nchang
    Elad, Peter Canisius Kuku
    Metzger, Wolfram
    Muhindo, Richard
    Chen, Qiushi
    Denkinger, Claudia M.
    McMahon, Shannon A.
    Chen, Simiao
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [37] Effects of COVID-19 in Endocrine Patients: A Cross-Sectional Study
    Morini, Elisabetta
    Maresca, Giuseppa
    Bonanno, Lilla
    Corallo, Francesco
    Lo Buono, Viviana
    De Cola, Maria Cristina
    MEDICINA-LITHUANIA, 2022, 58 (10):
  • [38] A cross-sectional study of COVID-19 outbreak in Indian population
    Arumugam, Murugesan
    Najimudeen, Raleena Begum Haja
    Vijayan, Arya
    Sathyamoorthy, Bhuvaneshwari
    Patole, Prashant S.
    ANNALS OF MEDICINE AND SURGERY, 2022, 76
  • [39] Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study
    Magalhaes, Joao Eudes
    Sampaio Rocha-Filho, Pedro A. A.
    JOURNAL OF NEUROVIROLOGY, 2023, 29 (04) : 472 - 478
  • [40] Repercussions of the COVID-19 pandemic on athletes: a cross-sectional study
    Lopes, Lucas R.
    Miranda, Vitor A. R.
    Goes, Rodrigo A.
    Souza, Gabriel G. A.
    Souza, Giuliana R.
    Rocha, Jessica C. S.
    Cossich, Victor R. A.
    Perini, Jamila A.
    BIOLOGY OF SPORT, 2021, 38 (04) : 703 - 711